Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 25 references it cites were found in a registry or an index; 3 of the 19 sources its claims cite were checked for support.

Serum levels of androgens and prostate-specific antigen in endometriosis

Open access
Evsen, M.S., Sak, M.E., Soydinc, H.E., Guven, S., Basaranoglu, S., Hatipoglu, N.K., Evliyaoglu, O., Gul, T. · 2014 · Clinical and Experimental Obstetrics & Gynecology

Abstract

OBJECTIVE: The aim of the present study was to evaluate the levels of serum androgens and prostate-specific antigen (PSA) levels in patients with endometriosis. MATERIALS AND METHODS: Patients with Stage III/IV (advanced stage) endometriosis were compared to controls with respect to basal serum levels of total testosterone (T), free testosterone (fT), androstenedion (A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulphate (DHEA-S), and PSA in the early follicular phase of menstrual cycle for this prospective case control study. RESULTS: Level of T, fT, A, DHEA, and DHEA-S were higher in patients with endometriosis when compared to control subjects, but the difference was not statistically significant. The mean PSA level was 0.0074 +/- 0.0120 ng/ml in patients with endometriosis and 0.0059 +/- 0.0056 ng/ml in control group and there was no statistically significant difference between groups (p = 0.58). CONCLUSION: Serum basal androgens and PSA levels are higher in endometriosis group with respect to control but the differences are not statistically significant.

Overview

CoChat Summary

TL;DR

In a prospective case-control study, serum androgens and prostate-specific antigen (PSA) tended to be higher in women with Stage III/IV endometriosis than in controls, but none of these differences were statistically significant. The authors conclude that basal androgens and PSA are higher in endometriosis without reaching significance.

Key findings

  • Total testosterone, free testosterone, androstenedione, DHEA, and DHEA-S were all higher in the endometriosis group than controls, but differences were not statistically significant: T 0.240 ± 0.124 vs 0.215 ± 0.057 ng/mL (p = 0.38); fT 1.674 ± 1.0139 vs 1.237 ± 0.432 ng/mL (p = 0.06); A 1.599 ± 1.279 vs 1.068 ± 0.946 ng/mL (p = 0.12); DHEA 9.439 ± 6.441 vs 7.348 ± 2.119 ng/mL (p = 0.38); DHEA-S 173.6 ± 74.01 vs 169.5 ± 59.9 μmol/mL (p = 0.93).
  • Mean PSA was 0.0074 ± 0.0120 ng/mL in endometriosis patients and 0.0059 ± 0.0056 ng/mL in controls, with no statistically significant difference (p = 0.58).
  • CA-125 and white blood cell count were significantly higher in the endometriosis group: CA-125 105.7 ± 164 vs 20.96 ± 8.16 U/mL (p < 0.001); WBC 8.444 ± 1.630 vs 6.261 ± 1.870 K/μL (p < 0.001).
  • Age, BMI, hematocrit, platelets, estradiol, FSH, LH, and prolactin did not differ significantly between groups.

Methods

  • Prospective case-control study conducted January to June 2012 at Dicle University Medical Faculty, Obstetrics and Gynecology Clinic.
  • After exclusions, the study included 24 women with laparoscopically/laparotomically and histologically confirmed Stage III/IV endometriosis and 25 controls undergoing surgery for benign gynecologic disorders such as dermoid cyst or tubal ligation.
  • Blood was drawn in the early follicular phase (day 2–4) after overnight fasting; PSA, FSH, E2, LH, and DHEA-S were measured by electrochemiluminescence immunoassay, and T, fT, A, and DHEA by radioimmunoassay. Groups were compared using Student’s t test or Mann-Whitney U test, with p < 0.05 considered significant.

Limitations

  • The paper states that the small sample size prohibits generalizability of the results.
  • The paper states that serum hormone levels may not correlate with the follicular microenvironment.
  • Evident from the text: Stage I/II endometriosis patients were excluded because of small sample size, and additional patients were excluded because PSA levels were unavailable, leaving a final sample of 24 endometriosis patients and 25 controls.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.12891/ceog16712014

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 0 Not valid · 10 Not checked · 13 Own results and interpretations

2 more claims

Create a free account to see all 25 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 12
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Citations

Cites

Research works printed but not linked: 1

  1. [1][1] Hesla J.S., Rock J.A.: 'Endometriosis'. In: Rock J.A., Jones H.W. (eds). Te Linde's Operative Gynecology . 10th ed. Philadelphia, Lippincott Williams-Wilkins, 2011, 438. -

Cited by

See all 5

Metadata

Authors
Evsen, M. S., Sak, M. E., Soydinc, H. E., Guven, S., Basaranoglu, S., Hatipoglu, N. K., Evliyaoglu, O., & Gul, T.
Affiliations
Dicle University (TR)
Corresponding author
Evsen, M.S.
Venue
Clinical and Experimental Obstetrics & Gynecology
Publisher
IMR Press
Published
2014-08-10
Volume
41
Issue
4
Pages
432-435
ISSN
0390-6663 (ISSN-L)
OpenAlex
W2401468627
Cited by
5
References
25
Citations by year
2025: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2014: 1
FWCI
0.40
Type
journal article
Language
en
Open access
Locations
  • Clinical and Experimental Obstetrics & Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
endometriosis, serum androgens, prostate-specific antigen, total testosterone, free testosterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, advanced-stage endometriosis, follicular phase
MeSH terms
Adult, Androstenedione, Dehydroepiandrosterone, Endometriosis, Female, Follicular Phase, Humans, Prospective Studies, Testosterone, Case-Control Studies, Prostate-Specific Antigen, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.